10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2010 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2010 10-K (Filed: Feb 18, 2011) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2010 | Dec 31, 2009 | |
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 3,648,371 | 8,809,339 |
| Investments, primarily time deposits and certificates of deposit | 1,803,079 | 1,122,709 |
| Restricted funds, primarily U.S. treasury bills | 1,872,490 | |
| Trade receivables, less allowances of - 2010: $388,564; 2009: $311,546; 2008: $263,632 | 7,184,034 | 6,541,941 |
| Inventories: | ||
| Finished products | 2,058,735 | 2,289,280 |
| Work in process | 383,580 | 448,487 |
| Materials | 746,419 | 527,110 |
| Total inventories | 3,188,734 | 3,264,877 |
| Deferred income taxes | 3,076,051 | 2,364,142 |
| Other prepaid expenses and receivables | 1,544,770 | 1,210,883 |
| Total Current Assets | 22,317,529 | 23,313,891 |
| Investments | 302,049 | 1,132,866 |
| Property and Equipment, at Cost: | ||
| Land | 648,988 | 546,204 |
| Buildings | 4,334,236 | 4,010,439 |
| Equipment | 11,813,618 | 11,325,450 |
| Construction in progress | 577,460 | 604,813 |
| Property and Equipment, at Cost | 17,374,302 | 16,486,906 |
| Less: accumulated depreciation and amortization | 9,403,346 | 8,867,417 |
| Net Property and Equipment | 7,970,956 | 7,619,489 |
| Intangible Assets, net of amortization | 12,151,628 | 6,291,989 |
| Goodwill | 15,930,077 | 13,200,174 |
| Deferred Income Taxes and Other Assets | 790,027 | 858,214 |
| Total Assets | 59,462,266 | 52,416,623 |
| Liabilities and Shareholders' Investment | ||
| Current Liabilities: | ||
| Short-term borrowings | 4,349,796 | 4,978,438 |
| Trade accounts payable | 1,535,759 | 1,280,542 |
| Salaries, wages and commissions | 1,328,665 | 1,117,410 |
| Other accrued liabilities | 6,014,772 | 4,363,032 |
| Dividends payable | 680,749 | 620,640 |
| Income taxes payable | 1,307,723 | 442,140 |
| Obligation in connection with conclusion of the TAP Pharmaceutical Products Inc. joint venture | 36,105 | |
| Current portion of long-term debt | 2,044,970 | 211,182 |
| Total Current Liabilities | 17,262,434 | 13,049,489 |
| Long-term Debt | 12,523,517 | 11,266,294 |
| Post-employment Obligations and Other Long-term Liabilities | 7,199,851 | 5,202,111 |
| Commitments and Contingencies | ||
| Shareholders' Investment: | ||
| Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
| Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2010: 1,619,689,876; 2009: 1,612,683,987; 2008: 1,601,580,899 | 8,744,703 | 8,257,873 |
| Common shares held in treasury, at cost - Shares: 2010: 72,705,928; 2009: 61,516,398; 2008: 49,147,968 | (3,916,823) | (3,310,347) |
| Earnings employed in the business | 18,927,101 | 17,054,027 |
| Accumulated other comprehensive income (loss) | (1,366,846) | 854,074 |
| Total Abbott Shareholders' Investment | 22,388,135 | 22,855,627 |
| Noncontrolling Interests in Subsidiaries | 88,329 | 43,102 |
| Total Shareholders' Investment | 22,476,464 | 22,898,729 |
| Total Liabilities and Shareholders' Investment | 59,462,266 | 52,416,623 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |